日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.

抗 CD20(利妥昔单抗)疗法用于治疗抗 IFN-γ 自身抗体相关的非结核分枝杆菌感染

Browne Sarah K, Zaman Rifat, Sampaio Elizabeth P, Jutivorakool Kamonwan, Rosen Lindsey B, Ding Li, Pancholi Minjal J, Yang Lauren M, Priel Debra Long, Uzel Gulbu, Freeman Alexandra F, Hayes Carlton E, Baxter Roger, Cohen Stuart H, Holland Steven M